Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2003

The fdxA ferredoxin gene can down-regulate frxA nitroreductase
gene expression and is essential in many strains of Helicobacter
pylori
Asish K. Mukhopadhyay
Washington University School of Medicine in St. Louis

Jin-Yong Jeong
Washington University School of Medicine in St. Louis

Daiva Dailidiene
Washington University School of Medicine in St. Louis

Paul S. Hoffman
Dalhousie University

Douglas E. Berg
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Mukhopadhyay, Asish K.; Jeong, Jin-Yong; Dailidiene, Daiva; Hoffman, Paul S.; and Berg, Douglas E., ,"The
fdxA ferredoxin gene can down-regulate frxA nitroreductase gene expression and is essential in many
strains of Helicobacter pylori." Journal of Bacteriology. 185,9. 2927-2935. (2003).
https://digitalcommons.wustl.edu/open_access_pubs/2812

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

The fdxA Ferredoxin Gene Can
Down-Regulate frxA Nitroreductase Gene
Expression and Is Essential in Many Strains
of Helicobacter pylori

Updated information and services can be found at:
http://jb.asm.org/content/185/9/2927
These include:
REFERENCES

CONTENT ALERTS

This article cites 52 articles, 34 of which can be accessed free
at: http://jb.asm.org/content/185/9/2927#ref-list-1
Receive: RSS Feeds, eTOCs, free email alerts (when new
articles cite this article), more»

Information about commercial reprint orders: http://journals.asm.org/site/misc/reprints.xhtml
To subscribe to to another ASM Journal go to: http://journals.asm.org/site/subscriptions/

Downloaded from http://jb.asm.org/ on May 4, 2014 by Washington University in St. Louis

Asish K. Mukhopadhyay, Jin-Yong Jeong, Daiva Dailidiene,
Paul S. Hoffman and Douglas E. Berg
J. Bacteriol. 2003, 185(9):2927. DOI:
10.1128/JB.185.9.2927-2935.2003.

JOURNAL OF BACTERIOLOGY, May 2003, p. 2927–2935
0021-9193/03/$08.00⫹0 DOI: 10.1128/JB.185.9.2927–2935.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Vol. 185, No. 9

The fdxA Ferredoxin Gene Can Down-Regulate frxA Nitroreductase
Gene Expression and Is Essential in Many Strains
of Helicobacter pylori
Departments of Molecular Microbiology and of Genetics, Washington University School of Medicine, St. Louis, Missouri,1 and
Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H72
Received 16 December 2002/Accepted 13 February 2003

Very few examples of metabolic regulation are known in the gastric pathogen Helicobacter pylori. An
unanticipated case was suggested, however, upon finding two types of metronidazole (Mtz)-susceptible strains:
type I, in which frxA (which encodes a nitroreductase that contributes to Mtz susceptibility) is quiescent, and
type II, in which frxA is well expressed. Here we report that inactivation of the fdxA ferredoxin gene (hp277) in
type I strains resulted in high-level frxA expression (in effect, making them type II). However, fdxA null
derivatives were obtained from only 6 of 32 type I strains tested that were readily transformed with an
frxA::aphA marker. This suggested that fdxA is often essential. This essentiality was overcome in 4 of 20 strains
by inactivating frxA, which suggested both that frxA overexpression is potentially deleterious and also that fdxA
has additional, often vital roles. With type II strains, in contrast, fdxA null derivatives were obtained in 20 of
23 cases tested. Thus, fdxA is dispensable in most strains that normally exhibit (and tolerate) strong frxA
expression. We propose that restraint of frxA expression helps maintain balanced metabolic networks in most
type I strains, that other homeostatic mechanisms predominate in type II strains, and that these complex
results constitute a phenotypic manifestation of H. pylori’s great genetic diversity.
Helicobacter pylori, the gram-negative pathogen implicated
in peptic ulcer disease and gastric cancer, chronically infects
more than half of all people worldwide and is one of the most
genetically diverse bacterial species (for reviews see references
14, 19,and 38). Independent clinical isolates typically differ by
3% or more in DNA sequences of representative housekeeping genes (2, 20) and by 5% or more in gene content (4, 5, 46).
Any two independent clinical isolates are usually distinguishable from one another by DNA fingerprinting (3) or by sequencing a few housekeeping genes (2, 20).
Inspection of the two fully sequenced H. pylori genomes had
revealed homologs of only a few of the regulatory genes known
from other bacterial species. This had suggested that H. pylori
might actually be relatively inflexible in a conventional regulatory sense; that is, it is hard wired for its special gastric niche
(5, 16, 52). It seemed, however, that H. pylori would achieve
phenotypic flexibility and diversity through mutation (56), interstrain and interspecies gene exchange and recombination
(30, 51, 52), and frameshift mutations in repetitive sequences,
the hallmark of highly mutable contingency genes (47, 52).
More-recent studies have demonstrated considerable regulation of gene expression in response to growth phase and environmental parameters, such as acidity and concentrations or
availability of iron, nickel, and other metals, and have identi-

fied more than a dozen genes with regulatory activity (15).
Another case of metabolic regulation was suggested by our
studies of susceptibility to the clinically important anti-H. pylori
drug metronidazole (Mtz) (27, 28, 50). Susceptibility results
from the action of one or two related nitroreductases that each
mediate conversion of Mtz from harmless prodrug to hydroxylamine, a bactericidal and mutagenic agent; RdxA, which is
abundant in essentially all Mtzs clinical isolates; and FrxA,
which is present at only very low levels in most isolates (designated type I strains) but at higher levels in others (type II
strains) (27, 28). RdxA and FrxA differ in substrate specificity
(49), but their normal substrates, products, and roles (e.g.,
whether purely metabolic or protective against reactive nitrogen and oxygen metabolites that are produced in the host
response to infection; see reference 40) are not known.
The two types of Mtzs strains can be distinguished provisionally in a forward mutation assay. Typically, Mtzr colonies are
found at frequencies of about 10⫺4 in cultures of type I strains
and are found at frequencies of ⱕ10⫺8 in cultures of type II
strains. This reflects the need to inactivate just one gene (rdxA)
rather than two genes (both rdxA and frxA) to achieve resistance (27, 28). Although frxA inactivation does not affect Mtz
susceptibility when rdxA is functional, its inactivation in type I
strains that are already mutated in rdxA usually increases resistance by about twofold (from 16 to 32 g/ml). This illustrates that frxA is expressed, but only weakly, in type I strains.
In accordance with this fact, frxA transcripts were detected by
reverse transcriptase PCR (RT-PCR) in both type I and type II
strains, but Northern blot analysis showed that they were abundant only in type II strains (27). In principle, the observed
patterns of frxA expression might reflect differences in a regulatory site or in a trans-acting regulatory factor.
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Here we identify a ferredoxin gene (fdxA; hp277 in the genome sequence) as a negative regulator of frxA gene expression and show that it is essential for many type I strains and
that part of this essentiality can involve restraint of nitroreductase gene expression.
MATERIALS AND METHODS

FIG. 1. RAPD analysis of relatedness. RAPD tests were carried
out on the related strain pairs 88-3887 and 26695 and also on X47 and
98QM3, as discussed in the text, by using primers 1247 (left eight
lanes), 1254 (top right eight lanes), 1281 (bottom left), and 1283
(bottom right) (3). The first and second lanes in each set contain
products of duplicate RAPD tests, carried out with 5 and 20 ng of
template DNA, to ensure that any differences seen are reproducible
(or to learn when they are not). Lanes labeled m contain 1-kb marker
size standards from Gibco-BRL.

These data showed that the residual Mtz susceptibility of rdxA-deficient 88-3887
involves its frxA gene, not some other function. We also note that frxA expression
seemed weaker in 88-3887 than in several other type II strains in that rdxA
inactivation in this strain did confer low-level Mtz resistance; it allowed colony
formation with 100% efficiency on medium with 3 g of Mtz per ml instead of
just 1 or 1.5 g per ml, as had been seen with SS1 and several other type II strains
(27, 28). Also noteworthy are the type II strains X47 and 98QM3 because of
differences in ease of fdxA inactivation (see below). Strain X47 derives from an
H. pylori strain that had been isolated from a domestic cat and that was then
adapted to mice by several sequential passages (18). 98QM3 was isolated from a
member of the same cat colony some 5 years later by D. Dailidene, K. W.
Simpson, and D. E. Berg and seemed closely related or identical to X47 in
RAPD fingerprint (no bands differed among more than 25 scored in tests with
four arbitrary primers; as in Fig. 1). Fifth, HUPB57 was considered type I
because, even though rdxA inactivation resulted in an MIC of 64 g/ml (higher
than that seen for most strains after rdxA inactivation), inactivation of frxA as well
as rdxA resulted in a higher level of resistance (MIC ⫽ 128 g/ml).
DNA methods. H. pylori genomic DNAs were isolated from confluent cultures
grown on BHI agar by using a Qiamp Tissue kit (Qiagen Corporation, Chatsworth, Calif.) or a standard cetyltrimethylammonium bromide phenol method
(4). RAPD fingerprint analysis was carried out essentially as described previously
(3) in 25-l reaction mixtures containing either 5 or 20 ng of genomic DNA (to
assess reproducibility of patterns), 5 mM MgCl2, 20 pM concentrations of a given
primer, 0.25 mM concentrations of each deoxynucleoside triphosphate, and 1 U
of Biolase thermostable DNA polymerase (Midwest Scientific) in a solution
containing 10 mM Tris-HCl (pH 8.3) and 50 mM KCl under the following cycling
conditions: 45 cycles of 94°C, 1 min; 36°C, 1 min; and 72°C, 2 min. Gene-specific
PCR was carried out in 20-l volumes containing 1 to 10 ng of genomic DNA, 10
pmol of each primer, 1 U of Biolase, and 0.25 mmol of each deoxynucleoside
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H. pylori culture conditions. H. pylori strains were grown on brain-heart infusion agar (BHI; Difco) supplemented with 7% horse blood, 0.4% Isovitalex, and
the antibiotics amphotericin B (8 g/ml) and trimethoprim (5 g/ml) (this solution is referred to hereafter as BHI agar) (27). Mtz was added to this medium
when needed at a concentration appropriate for the experiment, as detailed
below. The plates were incubated at 37°C under microaerobic conditions (5%
O2, 10% CO2, 85% N2). Transformation (electroporation) was carried out as
follows: exponentially growing H. pylori cells were harvested from BHI agar
(approximately 108 to 109 cells), washed twice in 10% glycerol, and suspended in
a final volume of 80 l of 10% glycerol at 4°C. Five micrograms of purified
plasmid DNA or PCR fragment was added to the cells for 1 min on ice. The
suspension of cells and DNA was transferred to a prechilled 0.2mm-gap electroporation cuvette and was subjected to single-pulse electroporation with an
initial voltage of 2.5 kV in a Bio-Rad Gene Pulser, spread on BHI agar, and
incubated for 24 h at 37°C. The cells were then transferred to BHI agar containing chloramphenicol (Cam) (15 g/ml), kanamycin (Kan) (20 g/ml), or Mtz (8
g/ml), as appropriate, and were incubated for 3 to 10 days, as needed, to select
for transformants.
Determination of Mtz susceptibility and resistance. H. pylori cells growing
exponentially on Mtz-free BHI agar were suspended in phosphate-buffered saline (PBS) buffer, a series of 10-fold dilutions of these cell suspensions was
prepared, and 10 l of each dilution was spotted on freshly prepared BHI agar
containing various concentrations of Mtz (0, 0.2, 0.5, 1.5, 3, 8, 16, 32, 64, and 128
g/ml) (essentially as described in references 27 and 28). The susceptibilities of
strains to Mtz are described here in terms of MIC, defined operationally as the
lowest of the Mtz concentrations listed above that reduces the efficiency of
colony formation by at least 10-fold. When Mtz-resistant mutants were rare
(⬍10⫺6) and accurate estimates of these frequencies were needed, culture aliquots were spread directly on the surface of an entire plate of Mtz-containing
BHI agar. We used this culture dilution protocol here because it is more sensitive
and reliable than traditional standard agar dilution or Etest methods for studying
Mtz susceptibility (MIC) in H. pylori, as detailed in reference 27.
H. pylori strains. The H. pylori strains used here were Mtzs clinical isolates
from diverse parts of the world. Most have been studied previously in other
contexts (27, 28, 31, 39). The type I (frxA quiescent) and type II (frxA expressed)
Mtzs H. pylori strains (as defined in references 27 and 28) that were used here
and their origins are as follows. Type I strains included 26695 (from the United
Kingdom) (52); TN2, GS3, HPK5, CPY6261, CPY6271, and CPY6311 (Japan);
HUPB48, HUPB57, HUPB63, HUPB71, HUPB72, and HUPB77 (Spain); Lit11,
Lit13, Lit50, Lit55, and Lit76 (Lithuania); Ind27, Ind66, Ind121, Ind92, Che5,
and Che13 (India); HK192 (Hong Kong); and PeCan9a (Peru). Type II strains
included SS1 (Australia); X47 (United States, mouse adapted, and ultimately
from a domestic cat; also known as X47-2AL [18]); 88-3887 (United Kingdom,
26695-related) (29 and Fig. 1); 98QM3 (from domestic cat; D. Dailidiene, K. W.
Simpson, and D. E. Berg, unpublished data); 2600, 2667, and 2714 (Texas) (32);
Lit5-34, Lit28-1, Lit43, Lit66-1, Lit75-1, Lit102, Lit113, Lit119, Lit120, and Lit122
(Lithuania); Alas219, Alas381, and Alas10103 (Alaska); Ind31 (India); R10
(South Africa); and HK152 (Hong Kong).
Five of these strains merit special comment. Strain 26695 (52) is nonmotile due
to a frameshift mutation in the fliP flagellar assembly gene and had come from
an initially mixed culture that also contained closely related motile cells, represented by strain 88-3887 (29). The relatedness of 26695 and 88-3887 is illustrated
in randomly amplified polymorphic DNA (RAPD) fingerprint data (Fig. 1; no
bands differed among some 25 scored in tests with four arbitrary primers). It was
important for the present study that mutational tests suggested that 88-3887
expressed frxA (type II Mtzs phenotype), whereas 26695 did not (type I). Most
critically, inactivation of strain 88-3887’s rdxA gene (transformation with an
rdxA::cat allele and selection for Camr, as described in references 21, 27, and 28)
left it vulnerable to Mtz: it formed colonies 103-fold and 106-fold less efficiently
on medium with 8 and 16 g of Mtz per ml, respectively, than on medium with
no Mtz or only 3 g of Mtz per ml (MIC ⫽ 8 g/ml). In contrast, rdxA
inactivation in strain 26695 allowed this strain to form colonies with 100%
efficiency on medium with up to 16 g of Mtz per ml (MIC ⫽ 32 g/ml).
Inactivation of both rdxA and frxA resulted in a MIC of 64 g/ml for both strains.
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TABLE 1. Primers useda
Primer

Sequence

Position of 5⬘ end

5⬘-CCGCAGCCAA
5⬘-AACGCGCAAC
5⬘-GCGATCCCCA
5⬘-GTGGATGCGA

Gene-specific
fdxA-F1
fdxA-R1
fdxA-F2
fdxA-R2
frxRT-F
frxRT-R
rdxART-F
rdxART-R
ureB-F
ureB-R

5⬘-CGCTTGTTCAAGGCTCTGATG
5⬘-CGCTACAAACTCCAGCCGATT
5⬘-GCCTCGTTGCGTGAGCGTAT
5⬘-CGCACGCAATGCATTCATCA
5⬘-GGACAGAGAACAAGTGGTTGCTT
5⬘-GCGAACCTAGAATTAGTGTCAT
5⬘-GCATGCTGTGGTTGAATCTCAC
5⬘-CGAGCGCCATTCTTGCAAGATGT
5⬘-CGTCCGGCAATAGCTGCCATAGT
5⬘-GTAGGTCCTGCTACTGAAGCCTTA

a

250 bp upstream of hp277 (fdxA)
300 bp downstream of hp277
144th nt of hp277 (fdxA)
18th nt of hp277
3rd nt of hp642 (frxA)
319th nt of hp642
367th nt of hp954 (rdxA)
42nd nt of hp954
781st nt of hp072 (ureB)
340th nt of hp072

The genes are listed according to their numerical designations in the genome sequence database of strain 26695 (52). nt, nucleotide.

triphosphate in standard PCR buffer. Gene-specific PCR entailed 2 min of
preincubation at 94°C followed by 30 cycles of 94°C, 40 s; 58°C, 40 s; and 72°C
for 1 min per kilobase pair, plus a final elongation step of 72°C for 10 min. The
genetic structures of transformants were checked by PCR to verify that they had
resulted from allelic replacement by using primers fdxA-F and fdxA-R, rdxA-F
and rdxA-R, or frxA-F1 and frxA-R1, as appropriate (see Table 1 for primer
sequences).
Mutant alleles used in strain construction. The rdxA::cat, rdxA⌬111, and
frxA::aphA alleles used to generate rdxA and frxA null mutant strains by DNA
transformation and selection for transformants by resistance to chloramphenicol,
metronidazole, and kanamycin, respectively, have been described previously (27,
28). An fdxA null allele was generated as follows: (i) PCR was used to amplify an
828-bp fdxA-containing DNA fragment from strain 26695 with primers fdxA-F1
and fdxA-R1 (Table 1); (ii) this fragment was cloned into a pBluescript plasmid
vector (Stratagene); (iii) the resultant clone was linearized by PCR with primers
fdxA-F2 and fdxA-R2 to delete 126 bp of fdxA; (iv) ligation of the linearized clone
DNA was performed with a minimal cat cassette (44); and (v) plasmids containing cat cassette inserts were selected and PCR was used to identify one in which
cat and fdxA are in the same orientation. This fdxA::cat DNA was used to
generate fdxA null H. pylori strains by DNA transformation. It is important to
note that the stem-loop structure that is just downstream of the open reading
frame in many cat cassettes has been removed here. This cassette is considered
nonpolar on distal gene expression, because its insertion between DNA segments
encoding the ␤ and ␤⬘ domains of the large ␤-␤⬘ RNA polymerase subunit
(normally fused in H. pylori) does not impair growth (44). An fdxA::aphA insertion allele that is probably polar on distal gene expression, because fdxA and
aphA are in opposite orientations, was generated similarly by using the aphA
cassette from the frxA::aphA allele.
Measurement of survival in stationary phase. Concentrated suspensions of
H. pylori cells that had been growing exponentially as overnight cultures on BHI
agar medium were prepared in PBS buffer (about 2 ⫻ 109 cells per ml), and 20
l (⬃4 ⫻ 107 cells) was spread uniformly on the surface of fresh BHI agar
(150-mm-diameter petri plate). The viability of this initial inoculum on each day,
beginning at day three, was determined by suspending aliquots of confluent
bacterial growth from these plates in PBS, measuring the optical density, and
determining viable counts by quantitative culture (CFU per optical density unit).
RT-PCR analysis of mRNA levels. Exponentially growing H. pylori strains were
spread on BHI medium alone or with Mtz (0.2 g/ml for SS1; 1.5 g/ml for
26695). Following 2 days of incubation, bacterial cells were collected and total
RNA was prepared by using a Qiagen RNeasy kit, as recommended by the
manufacturer (Qiagen Corp). After elution from the RNeasy column, the RNA
was treated with RNase-free DNaseI, extracted twice with phenol:chloroform,
and extracted once with chloroform-isoamyl alcohol. It was then precipitated
with ammonium acetate (final concentration of 2.5 M) and 2.5 volumes of
ice-cold ethanol, washed in 75% ethanol, and resuspended in RNase-free water.
The integrity of the 16S and 23S rRNA was checked on a 1% agarose gel.
Genomic DNA contamination was checked by PCR with Taq DNA polymerase
without RT. RT-PCR was carried out by using the One-Step RT-PCR kit

(Gibco-BRL) and primers frxRT-F and frxRT-R (for frxA mRNA), rdxRT-F and
rdxRT-R (for rdxA mRNA), and ureB-F and ureB-R (for ureB mRNA). RT-PCR
was carried out in a volume of 50 l in a Perkin-Elmer GeneAmp PCR system
2400 thermal cycler with the following conditions: 50°C for 20 min; 94°C for 2
min; and then 35 cycles of 94°C for 15 s, 58°C for 30 s, 72°C for 40 s, with a final
incubation at 72°C for 10 min.

RESULTS
The fdxA gene (hp277 in the strain 26695 genome sequence
[52]) encodes a [Fe4 S4]-type ferredoxin (5, 52), a carrier of
reducing equivalents, that may variously accept, donate, shift,
and/or store electrons in key steps in central metabolism (8).
The possibility that this protein’s redox potential might be low
enough to reduce Mtz and thereby convert it from prodrug to
bactericidal agent motivated our interest in testing whether
fdxA inactivation affected Mtz susceptibility. Others (32) had
also sought to study fdxA but were not able to obtain fdxA null
mutant transformants in their laboratory strain (2600). They
therefore concluded that fdxA is essential for viability (32). The
cat resistance gene cassette they had inserted into fdxA was
probably polar on distal gene expression (44); however, we
suspected that one or more of the genes downstream of and
probably cotranscribed with fdxA, which were annotated as
guanosine pentaphosphate pyrophosphatase (hp278), lipopolysaccharide heptosyltransferase (hp279), and lipid A acyltransferase (hp280) (5, 52), might be essential. Accordingly, we
decided to reexamine fdxA’s importance for H. pylori.
A nonpolar fdxA null allele was generated in cloned DNA by
replacing much of the fdxA sequence with a chloramphenicol
resistance determinant (cat) that lacks transcription pause sites
(44), and the resulting fdxA::cat DNA was used to transform
the type I reference strain 26695. Hundreds of Camr transformant colonies were obtained, as is typical with other DNAs
and this strain, although the colonies were slow growing (4
days, instead of 3, were needed to detect them by eye). PCR
with fdxA-specific primers confirmed that these Camr transformants had resulted from replacement of a wild-type allele with
the fdxA::cat allele (data not shown). Equivalent slow-growing
fdxA null transformants were also obtained with the type II
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TABLE 2. Efficiency of colony formation on
Mtz-containing mediuma
Strain

Mtzr frequency

a
Efficiency of colony formation on BHI agar containing 8 g of Mtz per ml.
When this efficiency is less than 1.0 (which implies that the strain is fully resistant
to Mtz), this frequency generally corresponds to frequencies of new Mtzr mutants, generated and selected by the mutagenic and bactericidal properties of
Mtz once activated.

mouse-adapted strain SS1. In contrast, attempts to generate
fdxA-deficient derivatives of these strains with a different null
allele, fdxA::aphA, which is probably polar on distal gene expression because fdxA and aphA are in opposite orientations,
were unsuccessful (no transformant colonies were scored as
ⱕ0.01% of normal yield), presumably because of polarity on
distal gene expression. We conclude that fdxA is not essential
for viability in strains 26695 or SS1, although it probably contributes to the vigor of their growth.
Three sets of results indicated that fdxA inactivation increased nitroreductase gene expression in strain 26695. First,
Mtzr mutants were found in cultures of fdxA null derivatives of
strain 26695 at frequencies of ⱕ10⫺8 (Table 2). This contrasts
with a frequency of about 10⫺4, which is characteristic of 26695
wild type, in which just one gene (rdxA) needs to be inactivated
to achieve Mtz resistance (27, 28, 50). Second, 26695 derivatives with null alleles of rdxA and fdxA (frxA functional) or of
frxA and fdxA (rdxA functional) each remained Mtzs but gave
rise to Mtzr mutants at frequencies of about 10⫺4 rather than
ⱕ10⫺8. A triple mutant, containing null alleles of both rdxA
and frxA as well as of fdxA (rdxA⌬111, frxA::aphA, fdxA::cat),
was Mtzr (Table 2). Thus, inactivation of frxA as well as rdxA
was needed to render the fdxA null derivative of 26695 resistant to Mtz. Third, RT-PCR indicated that fdxA inactivation
increased the frxA mRNA level about fivefold relative to that
of a ureB internal standard (Fig. 2). The rdxA transcript level
also seemed to be increased about twofold in the fdxA-null
derivative, which suggested that fdxA might help regulate both
nitroreductase genes. In contrast, fdxA inactivation in SS1,
which normally expresses frxA at a high level, did not affect frxA
or rdxA mRNA levels (Fig. 2). Further tests revealed similar
mRNA levels in cultures grown with sublethal levels of Mtz
(see the legend of Fig. 2). Collectively, these outcomes support
the view that the nitroreductase gene expression level inferred
from Mtz susceptibility patterns reflects bacterial genotype
(fdxA status) per se but not induction of gene expression by
Mtz or the cellular damage that it causes.
It is noteworthy that the rdxA frxA double mutant derivative
of 26695 was fully resistant to 32 g of Mtz per ml (100%
efficiency of colony formation), whereas the isogenic rdxA frxA
fdxA triple mutant exhibited full resistance only up to 16 g of
Mtz per ml in each of three independent trials (Fig. 3). The
quantitative differences in efficiency of colony formation by
double and triple mutants on plates with the critical 32 g of

FIG. 2. RT-PCR analysis of mRNA levels. H. pylori cells were
grown, RNA was extracted, and RT-PCR was carried out as detailed in
Materials and Methods. Threshold deleterious levels of Mtz were
included in BHI agar where indicated (0.2 g/ml for strain SS1; 1.5
g/ml for strain 26695). WT, wild type.
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26695 wild type (type I)............................................................ ⬃10⫺4
26695 rdxA.................................................................................. ⬃1.0
26695 frxA................................................................................... ⬃10⫺4
26695 fdxA .................................................................................. ⬍10⫺8
26695 fdxA rdxA......................................................................... ⬃10⫺4
26695 fdxA frxA.......................................................................... ⬃10⫺4
26695 fdxA rdxA frxA................................................................. ⬃1.0
SS1 wild type (type II).............................................................. ⬍10⫺8

Mtz per ml were seen when cells of each strain were spotted on
the same plate. The greater susceptibility of the triple mutant
might reflect either increases in other enzymes that also activate Mtz (28) or a nonspecific effect of the fdxA mutant’s less
vigorous growth.
fdxA is essential in most but not all type I Mtzs strains. The
generality of findings with strains 26695 was tested by using 31
additional transformable strains that had been classified as
type I by forward mutation tests (see Materials and Methods).
Expected yields of transformants (generally at least hundreds
of Camr colonies) were obtained with only two of them
(Ind121 and HUPB57) (Table 3). Mutational tests showed that
they each resembled 26695 in that fdxA inactivation in them
caused a decrease in the Mtzr mutant frequency from approximately 10⫺4 to ⬍10⫺8 and a need to inactivate both frxA and
rdxA, rather than only rdxA, to achieve Mtz resistance. Thus,
fdxA inactivation seemed to have turned on frxA expression in
these two type I strains.
Just a few Camr transformants were also obtained from 3 of
the other 29 type I isolates (Lit055, CPY6271, and HUPB48),
yields that were, in each case, less than 1% of those obtained
with frxA::aphA DNA used as an internal control in the same
transformation mixes. PCR tests indicated that some of these
rare Camr transformants still retained the wild-type fdxA allele,
suggesting that the fdxA::cat DNA had been inserted at another locus, perhaps by an illegitimate (mutation-like) recombination event (data not shown). However, at least one exceptional Camr transformant of each lineage was found by PCR to
contain fdxA::cat in place of the resident wild-type fdxA gene,
and these transformants were studied further. Inactivation of
fdxA in these three strains had also, in each case, caused reduction in frequencies of Mtzr mutants in young cultures from
⬃10⫺4 to ⱕ10⫺8. The Mtzr mutant frequencies were increased
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TABLE 3. Efficiency of recovery of fdxA::cat (null) transformants
depends on bacterial genotype
Frequency of recovery of
fdxA null transformants

Type I strains
Readily obtaineda
Obtained with difficultyb

FIG. 3. Profiles of susceptibility to Mtz of strain 26695 wild type
(WT) and isogenic mutant derivatives of it. Each test was carried out
at least three times.

again (to ⬃10⫺4) by further derivatives in which frxA had been
inactivated. This indicated that fdxA also helped down-regulate
frxA expression in these three exceptional type I strains.
No Camr transformants of any of the other 26 type I strains
were obtained in repeated transformations with fdxA::cat
DNA. In each case, the use of frxA::aphA DNA as a parallel
control or as an internal control in the same transformation
mix resulted in 100 or more Kanr transformants (Table 3), and
PCR tests showed that each strain did contain an fdxA gene.
Thus, fdxA seemed to be essential in most type I strains. It also
seemed that this essentiality could be relieved by suppressor
mutations in at least some strains (Lit055, CPY6271, and
HUPB48). The ease of generating fdxA null derivatives of
strains 26695, Ind121, and HUPB57 suggested that possibly
equivalent suppressors already preexist at low frequency in
natural populations.
fdxA is dispensable in most type II Mtzs strains. Replacement of resident fdxA alleles with the fdxA::cat null allele was
achieved readily in 20 of 23 type II strains tested (Table 3),

Obtained only after frxA
inactivation
Not obtained after frxA
inactivationc
Obtained only after frxA
and rdxA inactivation
Type II strains
Readily obtained
Not obtained
a

Fraction
of
strains

3 of 32
3 of 32
4 of 20
16 of 20
1 of 2

20 of 23
3 of 23

Examples

26695, Ind121, HUPB57
Lit055, CPY6271,
HUPB48
Ind27, Ind66, Chen13,
Lit050
Variousd
HK192e

SS1, 98QM3, 88-3887 and
others f
X47, HK152, R10

Readily obtained indicates that the yield of Camr fdxA null transformants was
similar to that of Kanr frxA null transformants generated with frxA::aphA DNAs
in the same transformation mix.
b
Obtained with difficulty indicates that the yield of Camr fdxA null transformants was ⬍1% that of Kanr frxA null transformants generated in the same transformation mix. In these cases, some Camr transformants did not contain allelic
replacements of the wild-type fdxA allele by the null mutant allele and thus may
have resulted from illegitimate recombination or some other mutation event.
c
Not obtained also indicates that the yield of Camr fdxA null transformants
was ⬍1% that of Kanr frxA null transformants generated in the same transformation mix. We do not know if the not obtained class differs from the obtained
with difficulty class.
d
These strains were TN2, GS3, HPK5, CPY6261, and CPY6311 (Japan);
HUPB63, HUPB71, HUPB72, and HUPB77 (Spain); A-11, A-13, and O76
(Lithuania); Ind92 and Chen5 (India); HK192 (HongKong); and PeCan9a (Peru).
e
Incorporation of frxA::aphA and rdxA⌬111 null mutations into HK192 allowed
recovery of slow-growing fdxA null transformants in high yield, whereas incorporation of these mutations into PeCan9a did not allow fdxA null transformants.
f
These additional strains were Lit5, Lit28-1, Lit43, Lit66-1, Lit75-1, Lit102, Lit113,
Lit119, Lit120, Lit122, Alas219, Alas381, Alas10103, 2600, 2667, 2714, and Ind31.
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although in each case fdxA null transformant colonies grew less
rapidly than did colonies of their fdxA-proficient parents.
Among the type II strains in which fdxA was readily inactivated
were (i) strain 2600, in which fdxA-null derivatives had first
been sought but without success (32), probably because of
transcription polarity (noted above); (ii) 88-3887, a 26695related strain that, remarkably, is type II in its Mtz-susceptible
phenotype (26695 is type I); and 98QM3, but not X47, which is
closely related to 98QM3 (see Fig. 1 and Materials and Methods).
No Camr transformant colonies were obtained from 3 of 23
type II isolates in repeated trials with fdxA::cat DNA (nonpolar
null allele) (X47, a North American isolate, HK152 from Hong
Kong, and R10 from South Africa), despite obtaining many
Kanr transformants with frxA::aphA control DNA. Each of
these three strains was retested and was confirmed as type II;
their Mtzs phenotypes were changed from stable (ⱕ10⫺8 Mtzr)
to metastable (⬃10⫺4 Mtzr) by inactivation of either rdxA or
frxA, and they became Mtzr if both rdxA and frxA were inactivated. Among these fdxA-requiring strains was X47, which is
remarkable because fdxA null derivatives of the closely related
strain 98QM3 were readily obtained. This indicates that small
differences in background genotype may determine whether
fdxA is essential or not.
Premature death in stationary phase. H. pylori cells began
dying soon after reaching stationary phase. Although death in
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FIG. 4. Kinetics of death in stationary phase. Young exponentially
growing cells were spread on BHI agar and were incubated. Aliquots
were withdrawn daily, and efficiencies of colony formation, relative to
culture optical density, were determined. WT, wild type.

stationary phase is not understood, we suspected that it might
be accelerated by disturbance of metabolic networks. Accordingly, the survivals of the wild-type strains 26695 and 88-3887
were compared with those of their isogenic fdxA derivatives
(Fig. 4). In each case, fdxA null derivatives tended to die more
rapidly than their wild-type parents in stationary phase, but the
kinetics of death seemed strain specific. By the time that the
viabilities of wild-type 88-3887 and 26695 had declined to
about 1% of the initial level, the viabilities of their fdxA null
derivatives had declined another ⬃400-fold and ⬃20-fold, respectively (Fig. 4). This was seen in each of two independent
trials, each with an independently constructed fdxA null transformant. The fdxA null derivative of the unrelated SS1 strain
also died prematurely in stationary phase, with a severity similar to that of strain 26695 but not 88-3887 (data not shown).
Given that 88-3887 and 26695 are closely related, it would
seem that effects of fdxA on fitness can also be strongly affected
by small differences in background genotype.
Lethality of fdxA inactivation can involve frxA. One explanation for fdxA’s essentiality in many type I strains and dispensability in most type II strains supposes that high FrxA
nitroreductase levels are deleterious in strains of particular
genotypes. This idea is based on indications that inactivation of
fdxA caused increased frxA expression in at least some type I
strains, that fdxA seemed to be essential in most type I strains,
and that fdxA was dispensable in most type II strains. To test
this idea, we made frxA null (frxA::aphA) transformants of 20
representative fdxA-requiring type I strains and transformed
frxA null derivatives of each lineage with fdxA::cat DNA. Camr
transformant colonies were obtained at normal frequency in
four lineages (Ind27, Ind66, Chen13, and Lit050) (Table 3). In

fdxA, an often essential regulatory gene. The possibility of
metabolic regulation of nitroreductase gene expression in H.
pylori emerged first with the finding of two types of Mtzs clinical isolates: type I, in which frxA is relatively quiescent; and
type II, in which frxA is highly expressed (27, 28). Here we
report that (i) fdxA (hp277, ferredoxin gene) helped downregulate frxA expression in some type I H. pylori strains; (ii) the
fdxA gene was essential for viability in many of them; (iii) this
essentiality reflected a need to restrain frxA expression, at least
in some cases; and (iv) fdxA was dispensable in most type II
strains (which naturally express frxA). The complexity of these
results—the inability to predict with certainty how any one
strain will behave based on findings with other strains—provides a new phenotype-level illustration of H. pylori’s great
genetic diversity and may give insight into how this gastric
pathogen evolves and interacts with its human hosts during
long-term chronic infection.
The involvement of fdxA in down-regulating frxA expression
was most evident in six type I strains that tolerated fdxA inactivation; in each case, this caused a need to mutate frxA (along
with rdxA) to achieve Mtz resistance. The repeated failure to
obtain fdxA null transformants of most other type I strains,
however, indicated that FdxA was often essential. Although a
failure to obtain fdxA null transformants of strain 2600 had also
been interpreted as indicating fdxA essentiality (32), that particular result can now be ascribed to polarity on distal gene
expression, because fdxA null derivatives of strain 2600 were
readily generated here by using a nonpolar fdxA::cat allele.
The requirement for fdxA was overcome in 4 of 20 strains by
inactivating their frxA genes. This suggested that FdxA protein
also regulated frxA expression in these strains and that keeping
frxA quiescent was an adaptive trait for them. Indications of
additional roles for fdxA included our inability to obtain fdxA
null transformants in most type I strains, even after making
them frxA deficient; the slow growth of fdxA null transformants
(although some of this might also be ascribed to residual polarity of the cat cassette used to inactivate fdxA); and their
premature death in stationary phase. This additional role(s)
may include carriage of reducing equivalents for multiple metabolic reactions and possibly also regulating expression of additional genes (8, 9).
In light of fdxA’s essentiality in most type I strains, it was
striking that fdxA null derivatives were obtained in most type II
strains, the class that normally exhibits (and tolerates) strong
frxA expression. This might reflect either (i) the presence in
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each case, the colonies obtained were much smaller and slower
growing than those made by the parental (frxA-deficient but
fdxA-functional) strain. PCR tests of two single-colony isolates
and of pools of 20 to 50 transformants from each lineage
demonstrated the expected allelic replacement (original fdxA
allele by fdxA::cat allele) in each case. This suggests that fdxA’s
essentiality in some type I strains reflects the ability of its gene
product to down-regulate frxA gene expression. However, the
inability to obtain fdxA null transformants of frxA null derivatives of 16 of these 20 selected type I strains and the slow
growth of fdxA null transformants, when obtained, indicated
that fdxA must have additional role(s).
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lation of numerous genetic differences, many of which may
have quantitative effects on metabolite flux in one or more
biochemical pathways. The following possible sources of this
diversity have been much discussed: general mutation (56),
frameshifts in repetitive sequences in contingency genes
(47), and recombination within and between strains (24, 29,
51, 52). We suggest that the present level of diversity also
reflects several additional features: (i) H. pylori’s mode of
transmission, which is preferentially intrafamilial and occurs
efficiently in early childhood (7, 13, 23, 36); (ii) the tendency
of infections to persist for decades; and (iii) the rarity of new
infections in adulthood (1, 37, 55). These three features
create a highly fragmented bacterial population and diminish competition among strains from unrelated persons and
selection for any one or few potentially most-fit genotypes
(selective sweeps [22]). These features would promote genetic drift even if all people were identical physiologically.
Given human diversity in traits that may be important to
individual H. pylori strains (17, 24, 35, 43), we also imagine
that at least subtly different phenotypes may be selected in
different infected people. These features of H. pylori and of
human populations create, in effect, rugged evolutionary
landscapes (12, 53, 57). The chance of ingestion, especially
in infancy, as much as any near-ideal match between bacterial genotype and particular host physiology may dictate
which H. pylori strain becomes established in any new human host. This feature should often result in selection for
adaptive changes that make each infecting strain better
suited for its present host. The selection for adaptive
changes may continue for years, in part because gastric
physiology changes with age and in response to chronic
infection. Adaptation will often involve many small steps
and operate along different trajectories in different strains
and infected people (12, 43, 54, 57)—Jacob’s concept of
evolution by tinkering (25). The resultant constellations of
quantitative trait determinants should, in turn, affect the
chance that a given strain will productively infect a particular human host and the chance that persistent infection will
lead to overt disease.
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